Stereotactic body radiotherapy was associated with significantly better urinary continence and fewer sexual issues at 2 years ...

Men with localized prostate cancer were randomly assigned to receive either SBRT or control radiotherapy in a phase 3 trial.

In metastatic hormone-sensitive prostate cancer (mHSPC), adding the radioligand 177 Lu-PSMA-617 (Pluvicto) to androgen ...

Men with prostate cancer diagnosed at an early stage may be able to slow the progression of their disease by adopting a ...

In a study believed to be the first of its kind published, a research team led by Johns Hopkins Medicine provides scientific ...

Increase of 11,000 cases means more men face risk of deadlier late-stage disease ...

Exclusive: “Unfortunately, most of the genetic research that had been published focused only on people of white, European ...

Prostate cancer is the second leading cause of cancer death among American men. A recent study, conducted by researchers from ...

The legacy of Steve Abbott helped a local organization save lives by raising awareness about early detection of the disease.

Stereotactic body radiotherapy (SBRT) is noninferior to conventional or moderately fractionated radiotherapy for loc ...

Black men with advanced prostate cancer have a greater chance of survival after immunotherapy treatment, at least in part, ...

Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...